Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „Systemic“
Suchtreffer
Begriffe & Kennungen
Immunoglobulin-Leichtketten-Amyloidose
Eintrag öffnenInbrija · 4.5 · Interactions of Inbrija with local or systemic pulmonary medicinal products were not investigated because Inbr
Eintrag öffnenInbrija · 4.5 · Local or systemic pulmonary medicinal products
Eintrag öffnenIncrelex · 4.8 · 6 Immune system disorders Not known: Systemic hypersensitivity (anaphylaxis, generalized urticaria, angioedema
Eintrag öffnenIncrelex · 4.8 · Systemic/local hypersensitivity Clinical Trial During clinical trials in other indications (totaling approxima
Eintrag öffnenIndolente systemische Mastozytose
Eintrag öffnenInhixa · 4.5 · 104 - Systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, and NSAIDs including ketorolac, -
Eintrag öffnenInhixa · 4.5 · 42 - Systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, and NSAIDs including ketorolac, -
Eintrag öffnenInhixa · 4.5 · 73 - Systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, and NSAIDs including ketorolac, -
Eintrag öffnenIntrarosa · 4.5 · Concomitant use with systemic HRT (oestrogen-only or oestrogen-progestagen combination or androgen treatment)
Eintrag öffnenJanumet · 4.5 · Glucocorticoids (given by systemic and local routes) beta-2-agonists, and diuretics have intrinsic hyperglycae
Eintrag öffnenJemperli · 4.8 · Immune-related hepatitis Hepatitis occurred in 3 (0.5 %) patients, all of which were grade 3. Systemic cortico
Eintrag öffnenJemperli · 4.8 · Systemic corticosteroids (prednisone ≥ 40 mg per day or equivalent) were required in 11 (78.6 %) patients expe
Eintrag öffnenJemperli · 4.8 · Systemic corticosteroids (prednisone ≥ 40 mg per day or equivalent) were required in 5 (62.5 %) patients. Coli
Eintrag öffnenJentadueto · 4.5 · Metformin Combination requiring precautions for use Glucocorticoids (given by systemic and local routes), beta
Eintrag öffnenJoenja · 4.5 · OAT3 substrates Leniolisib is an OAT3 inhibitor and may increase systemic exposure to OAT3 substrates (e.g., a
Eintrag öffnenKalydeco · 4.5 · Administration of ivacaftor may increase systemic exposure of medicinal products that are sensitive substrates
Eintrag öffnenKalydeco · 4.5 · Administration of ivacaftor may increase systemic exposure of medicinal products that are sensitive substrates
Eintrag öffnenKesimpta · 4.8 · Systemic injection-related reactions In the RMS phase III clinical studies, SIRRs were reported in 20.6% of pa
Eintrag öffnenKeytruda · 4.5 · The use of systemic corticosteroids or immunosuppressants before starting pembrolizumab should be avoided beca
Eintrag öffnen